Burkholderia cenocepacia and Burkholderia multivorans:: influence on survival in cystic fibrosis
Burkholderia cenocepacia and Burkholderia multivorans:: influence on survival in cystic fibrosis
复制标题
DOI:
10.1136/thx.2003.017210
复制
发表时间:
2004-11-01
期刊:
影响因子:
10
通讯作者:
Webb, AK
中科院分区:
文献类型:
--
作者:
Jones, AM;Dodd, ME;Webb, AK
Introduction: Burkholderia cepacia infection has been associated with a poor prognosis for patients with cystic fibrosis (CF). It is now recognised that organisms classified as B cepacia comprise a number of distinct genomic species each known as a genomovar of the B cepacia complex (BCC). The outcome of infection for CF patients with individual genomovars is unknown. The clinical outcome of infection with the two most commonly isolated genomovars (B cenocepacia and B multivorans) was studied at a specialist CF centre between 1982 and 2003.Methods: The numbers of patients who progressed from initial to chronic infection were assessed. Control groups were created by matching patients with chronic BCC infection by percentage forced expiratory volume in 1 second with patients with Pseudomonas aeruginosa infection. Outcome measures were survival time, deaths from "cepacia syndrome'', rate of decline in spirometry and body mass index (BMI), and treatment requirements.Results: Forty nine patients had an initial infection with either B multivorans (n=16) or B cenocepacia (n=33); 8/16 and 31/33, respectively, developed chronic infection (p